Anteris Technologies Ltd (AVR:ASX)
$7.11
-0.11 (-1.52%)
MCAP $46.70M
Last trade 16.10pm 26/02/2021
20mins delayed
Latest Announcements
25/02/2021AVRAnteris Technologies Ltd
855
MCap
18/02/2021 Price SensitivePSAVRAnteris Technologies Ltd
308
MCap
18/02/2021 Price SensitivePSAVRAnteris Technologies Ltd
6,694
MCap
17/02/2021AVRAnteris Technologies Ltd
22/01/2021 Price SensitivePSAVRAnteris Technologies Ltd
4,119
MCap
22/01/2021AVRAnteris Technologies Ltd
355
MCap
20/01/2021AVRAnteris Technologies Ltd
411
MCap
20/01/2021AVRAnteris Technologies Ltd
169
MCap
Company Overview
Anteris Technologies Ltd, formerly Admedus Ltd, is an Australia-based structural heart company. The Company provides solutions for heart valves. Its products include ADAPT and DurAVR. ADAPT its anti-calcification treatment platform technology on which its structural heart products are developed. DurAVR, built with ADAPT technology, is a durable three dimension (3D) single-piece aortic valve for the treatment of aortic stenosis. Its DurAVR Development Portfolio includes DurAVR Leaflet Repair (RP), DurAVR Transcatheter Heart Valve (THV) and DurAVR Surgical Heart Valve (SHV).
